Charles River Laboratories | CRL - 销售收入

股票价格
169.80
每天变化
2.06 1.23%
每月一次
2.36%
每年
48.09%
Q2 预测
166.17


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.75B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


销售 更改 日
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Cardinal Health USD 65.63B 1.63B 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Cigna USD 72.47B 2.77B 2025-12
Concord Medical Services Hldg CNY 200.61M 83.9M 2025-06
CVS Health USD 105.7B 2.8B 2025-12
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 961M 57M 2025-12
Elevance Health USD 49.5B 200M 2026-03
Galapagos EUR 900.82M 835.52M 2025-12
Humana USD 32.52B 130M 2025-12
Illumina USD 1.16B 80M 2025-12
Incyte USD 1.51B 140M 2025-12
Intrexon USD 717K 511K 2024-06
IQVIA Holdings USD 4.36B 260M 2025-12
Laboratory Of America USD 3.52B 40M 2025-12
Lonza CHF 3.58B 63M 2025-06
McKesson USD 106.16B 3.01B 2025-12
Merck EUR 5.25B 70M 2025-12
Mettler Toledo International USD 1.13B 100M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Revvity USD 772.06M 73.06M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
United Therapeutics USD 790.2M 9.3M 2025-12
UnitedHealth USD 111.7B 1.5B 2026-03
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 932M 132M 2025-12
West Pharmaceutical Services USD 844.9M 39.9M 2026-03